Overvalued HBAN

MS
mschoen25
Invested
Community Contributor
Published
27 Sep 24
Updated
27 Sep 24
mschoen25's Fair Value
US$10.11
59.1% overvalued intrinsic discount
27 Sep
US$16.09
Loading
1Y
18.2%
7D
0.3%

Author's Valuation

US$10.1

59.1% overvalued intrinsic discount

mschoen25's Fair Value

Huntington Bancshares (HBAN) is currently trading around $14.56, with analysts offering a consensus 12-month price target of $15.59, suggesting a potential upside of around 7%. The stock has been rated as a "Moderate Buy" by most analysts, with 12 out of 19 giving it a "Buy" or "Strong Buy" recommendation. The price targets range from a low of $13.50 to a high of $18.00, which implies a wide range of possible outcomes depending on market conditions.

The stock has gained about 14.5% year-to-date, reflecting steady performance. While it may not be deeply undervalued, analysts believe it still has room for growth. That said, the company's price-to-earnings ratio of around 10.4 and forward earnings growth could make it attractive to value investors​

How well do narratives help inform your perspective?

Disclaimer

The user mschoen25 has a position in NasdaqGS:HBAN. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives